A database analysis by the Early Breast Cancer Trials Collaborative Group (EBCTCG ) showed that obesity in early-stage breast cancer was only associated with increased breast cancer mortality in pre- and perimenopausal hormone receptor-positive (HR+) patients. A new study with a much larger patient population has now been presented at the SABCS [1].
Autoren
- Birke Dikken
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- COPD: Tailor therapy to individual characteristics
Risk of exacerbation correlates with the eosinophil count and other factors
- Focus on new therapeutic targets and senolytics
Cellular senescence
- Development of a quintuple agonist
New strategy in the fight against obesity and T2D
- From symptom to diagnosis
Oncocytoma
- Arterial elasticity, vascular ageing, endothelial function
Longevity and cardiovascular health 2025
- AI-supported risk stratification for chest pain in the emergency room
Performance of a fully automated ECG model
- Alternative to insulin and GLP1
From the β-cell to the center: the versatile role of amylin
- Hormone balance and longevity